14:53 EDT Bayer Roundup cancer verdict cut 60% to $600M, Bloomberg reports
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Opening Day: Bayer-backed Boundless Bio falls after IPO
- Bayer, Lavie Bio continue biofungicides validation
- Crispr Therapeutics proposes to elect Christian Rommel to board of directors
- Bayer says ‘structural change is not the current optimal course of action’
- Bayer price target lowered to EUR 28 from EUR 30 at Barclays